
Tirzepatide has become the most talked-about medication in medical weight loss, and for good reason. It is the only FDA-approved therapy that works on two separate appetite and metabolism hormone pathways at once, and in clinical trials it produced the largest average weight loss of any pharmaceutical option available today. At Contour Medical Clinic in Tarzana, tirzepatide is prescribed and monitored by physicians as part of a complete program, not handed over as a shot with no follow-up. Here is what the medication is, how it compares to semaglutide, what dosing and side effects really look like, and what changed in 2026 that every patient considering it should know.
Tirzepatide is a once-weekly injectable medication sold under two brand names: Zepbound, approved for chronic weight management and obstructive sleep apnea in adults with obesity, and Mounjaro, approved for type 2 diabetes. What sets it apart is its mechanism. Semaglutide (Ozempic, Wegovy) activates a single hormone receptor, GLP-1. Tirzepatide activates two, GLP-1 and GIP, both of which play a role in appetite regulation, insulin sensitivity, and digestion. Activating both pathways appears to produce a stronger effect on appetite and fullness than GLP-1 therapy alone, which is reflected in the head-to-head weight loss data below.
In the SURMOUNT-1 clinical trial, adults with obesity who were not diabetic lost an average of 20.9% of their body weight at the highest studied dose (15 mg) over 72 weeks, compared to roughly 3% in the placebo group. Even patients who stayed on the lowest maintenance dose still lost a clinically meaningful amount of weight, and follow-up analyses have shown some patients achieving reductions in the low 20s percent range. For context, that places tirzepatide at the upper end of what is currently achievable with medication, ahead of the roughly 15% average seen with semaglutide in the STEP 1 trial. Individual results always depend on starting weight, final dose, adherence, and whether the medication is paired with nutrition and lifestyle support, which is why Contour Medical Clinic builds a full program around the prescription rather than treating the injection as the whole plan.
Tirzepatide is not started at a full dose. The FDA-labeled titration schedule begins at 2.5 mg once weekly for four weeks, a starting dose meant to let your body adjust rather than produce weight loss on its own. From there, dosing typically increases every four weeks: 5 mg, then 7.5 mg, then 10 mg, then 12.5 mg, and finally 15 mg, if needed. Research shows the 5 mg dose alone can produce roughly 15% average body weight reduction by 72 weeks, so reaching the maximum 15 mg dose is not a requirement for meaningful results. At Contour Medical Clinic, your titration pace is adjusted based on how you tolerate each step, your labs, and your goals, rather than following a fixed calendar regardless of how you are responding.
The most frequently reported side effects of tirzepatide are gastrointestinal: nausea, vomiting, diarrhea, decreased appetite, constipation, and upper abdominal discomfort. These effects are most noticeable during dose increases and typically ease as your body adjusts. Slower titration, dietary adjustments (smaller meals, less fat and sugar early on), and staying hydrated all help. This is one of the clearest advantages of physician-supervised care: a clinician who can slow your titration schedule or adjust supportive measures tends to resolve these issues considerably faster than navigating them without guidance.
Tirzepatide is generally appropriate for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. It is not appropriate for everyone. A personal or family history of certain thyroid tumors (medullary thyroid carcinoma or MEN 2), a history of pancreatitis, pregnancy or breastfeeding, and some gastrointestinal conditions can rule out tirzepatide or require closer monitoring. Every consultation at Contour Medical Clinic starts with a full health history, current medication review, and baseline labs so your care team can confirm candidacy before you start, and continue monitoring you throughout treatment.
Both medications are legitimate, FDA-approved options, and the right choice depends on your health history, goals, and how your body responds. Tirzepatide's dual mechanism is associated with somewhat greater average weight loss in head-to-head data, but semaglutide has a longer real-world track record and may be preferable for patients with certain medication interactions or side effect sensitivities. Our companion guide on Medical Weight Loss in Tarzana walks through both medications side by side in more detail. During your consultation, your physician will recommend the option that fits your specific labs, history, and goals rather than defaulting to whichever medication is trending.
During the national tirzepatide shortage, compounded versions became widely available through telehealth services and med spas. That shortage was declared resolved by the FDA in December 2024, and the regulatory grace period that allowed broad compounding has since narrowed considerably. In 2026, compounded tirzepatide can generally only be legally prescribed for a documented medical need that an FDA-approved formulation cannot meet, such as a verified allergy to an inactive ingredient, and only through a state-licensed pharmacy on a patient-specific prescription. Contour Medical Clinic prescribes FDA-approved branded tirzepatide, Zepbound or Mounjaro, sourced through licensed pharmacies, so patients are not left navigating the legal gray areas that surround many compounded weight loss products today.
Your first visit is a medical consultation, not a prescription handed across a counter. Expect a conversation about your weight and health history, current medications, and goals; a physical exam and baseline labs where appropriate; a clear, side-by-side explanation of tirzepatide versus semaglutide and which fits your situation; and a straightforward discussion of cost, timeline, and realistic expectations. If you are a candidate, you will also receive hands-on injection training so you feel confident administering your own weekly dose at home.
Clinical trial averages range from about 15% to 21% of body weight over roughly 72 weeks depending on final dose, though individual results vary based on starting weight, adherence, and whether the medication is combined with nutrition and lifestyle support.
Tirzepatide has been studied in trials extending well beyond a year, with side effects that are typically gastrointestinal and most pronounced during dose increases. Ongoing physician monitoring, including periodic labs, is part of using it safely over time.
That depends on your response, goals, and health history, and it is a conversation for your care team. Some patients transition to a lower maintenance dose, while others shift focus to nutrition and lifestyle changes to help sustain results after completing treatment.
Coverage varies widely by plan, diagnosis, and whether the medication is prescribed for diabetes or weight management. Our team can review your options and current program pricing during your consultation.
Medical Weight Loss in Tarzana: Semaglutide, Tirzepatide & Physician-Supervised Care
5 Signs You're Ready for a Medical Wellness Consultation at Contour Medical Clinic in Tarzana
If you want the most effective medical weight loss option available today, backed by physician oversight instead of a one-time prescription, Contour Medical Clinic's tirzepatide program in Tarzana includes lab monitoring, dose titration support, and a plan that adapts as you progress. Serving Tarzana, Woodland Hills, Encino, and the greater San Fernando Valley. Schedule your consultation today.